Bolt Biotherapeutics Inc

The current institutional shareholding score of Bolt Biotherapeutics Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 26.88%, representing a quarter-over-quarter decrease of 51.40%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 4.02% of shares outstanding, with 0.03% increase in holdings.